HOME > TOP STORIES
TOP STORIES
-
REGULATORY Gist of FY2026 Drug Pricing Reform Outline
December 26, 2025
-
REGULATORY Japan Puts CEA Expansion on Hold, Sets 6-Month “Technical Discussions”
December 26, 2025
-
REGULATORY Chuikyo OKs FY2026 Drug Pricing Reform Outline, Scraps “Spillovers” but Adds New Follow-Up Rules
December 26, 2025
-
REGULATORY MHLW Names 77 Active Ingredients for OTC-Like Drug Charges
December 26, 2025
-
REGULATORY Japan Ministers Agree to Scrap “Spillover” Rule, Plan Wider CEA Price Cuts
December 25, 2025
-
REGULATORY Japan Weighs Scrapping “Spillover” Rule in Shift from Draft Reform Outline
December 24, 2025
-
BUSINESS Cyto-Facto Expands CPC Footprint to Win Multiple Cell Therapy Contracts
December 24, 2025
-
REGULATORY Japan Approves Batch of New Drugs, Subcutaneous Rybrevant Finally Cleared
December 23, 2025
-
TRENDS Top 10 PHARMA JAPAN Articles of 2025
December 23, 2025
-
REGULATORY LDP, Ishin Strike Deal on OTC-Like Drugs, Patients to Pay “1/4” Special Charge
December 22, 2025
-
REGULATORY LDP, Ishin Finalize FY2026 Tax Reform Outline, Strategic Tech R&D Credit Codified
December 22, 2025
-
BUSINESS Sanofi Bets on Immunotherapy to Delay Onset of Type 1 Diabetes
December 19, 2025
-
REGULATORY LDP, Ishin Fail to Seal Deal on OTC-Like Drugs as Talks Stall over Fiscal-Savings Figure
December 18, 2025
-
BUSINESS AI-Driven Target Discovery Gains Ground among Japanese Pharma: FRONTEO CEO
December 17, 2025
-
ORGANIZATION Pharma Groups Reiterate “No” to Broader CEA Use, Huge-Seller and Spillover Rules: Joint Statement
December 17, 2025
-
BUSINESS Pfizer Targets Double-Digit Oncology Growth in Japan over Next 5 Years
December 16, 2025
-
REGULATORY Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests
December 15, 2025
-
REGULATORY LDP Tax Panel OKs New 40% R&D Credit for Strategic Technologies
December 12, 2025
-
BUSINESS AG Price Parity Plan Stokes Industry Fears of Patient, Pharmacy Defections
December 12, 2025
-
REGULATORY Pharma Renews Call to Scrap “Spillover,” “Huge-Seller” Rules as FY2026 Talks Enter Final Stretch
December 11, 2025
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
